Maija Hollmen
Affiliations: | 2014-2017 | MediCity | University of Turku, Åbo, Finland |
Google:
"Maija Hollmen"Mean distance: (not calculated yet)
Parents
Sign in to add mentor| Sirpa Jalkanen | post-doc | 2014-2017 | University of Turku | |
| (Now Adjunct Professor) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Viikinkoski E, Aittokallio J, Lehto J, et al. (2023) Prolonged Systemic Inflammatory Response Syndrome After Cardiac Surgery. Journal of Cardiothoracic and Vascular Anesthesia |
| Rannikko JH, Bono P, Hynninen J, et al. (2023) Bexmarilimab activates human tumor-associated macrophages to support adaptive immune responses in interferon-poor immune microenvironments. Cancer Immunology Research |
| Jalkanen J, Khan S, Elima K, et al. (2023) Polymorphism in interferon alpha/beta receptor contributes to glucocorticoid response and outcome of ARDS and COVID-19. Critical Care (London, England). 27: 112 |
| Hua Y, Vella G, Rambow F, et al. (2023) Cancer immunotherapies transition endothelial cells into HEVs that generate TCF1 T lymphocyte niches through a feed-forward loop. Cancer Cell. 41: 226 |
| Hua Y, Vella G, Rambow F, et al. (2022) Cancer immunotherapies transition endothelial cells into HEVs that generate TCF1 T lymphocyte niches through a feed-forward loop. Cancer Cell |
| Moisio O, Virta J, Yatkin E, et al. (2022) Preclinical Evaluation of a Humanized Antibody Against Common Lymphatic Endothelial and Vascular Endothelial Receptor-1, Zr-Desferrioxamine-Bexmarilimab, in a Rabbit Model of Renal Fibrosis. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine |
| Spourquet C, Delcorte O, Lemoine P, et al. (2022) BRAF Expression in Thyrocytes Causes Recruitment of Immunosuppressive STABILIN-1 Macrophages. Cancers. 14 |
| Mutka M, Virtakoivu R, Joensuu K, et al. (2022) Clever-1 positive macrophages in breast cancer. Breast Cancer Research and Treatment |
| Hollmén M, Maksimow M, Rannikko JH, et al. (2022) Nonclinical characterization of bexmarilimab, a Clever-1-targeting antibody for supporting immune defense against cancers. Molecular Cancer Therapeutics |
| Viikinkoski E, Jalkanen J, Gunn J, et al. (2021) Red blood cell transfusion induces abnormal HIF-1α response to cytokine storm after adult cardiac surgery. Scientific Reports. 11: 22230 |